Health care regulation firm Frier Levitt has analyzed FDA enforcement actions versus “research only” peptide vendors. Their conclusion: the FDA considers an item’s classification according to its supposed use, not its disclaimers. When Internet websites include dosage guides, reconstitution Guidelines, or url to message boards speaking about